Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
04/2010
04/08/2010US20100087509 Methods, Agents, and Compound Screening Assays for Inducing Differentiation of Undifferentiated Mammalian Cells into Osteoblasts
04/08/2010US20100087507 Use of rpn2 gene expression inhibitor
04/08/2010US20100087462 Methods for predicting and detecting intolerance to an hypolipidemic agent
04/08/2010US20100087441 Prognostic Method
04/08/2010US20100087387 Five- and six-membered conformationally locked 2',4'-carbocyclic ribo-thymidines for the treatment of infections and cancer
04/08/2010US20100087379 Polypeptides of botryosphaeria rhodina
04/08/2010US20100087376 Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
04/08/2010US20100087353 Novel Variant EGIII-Like Cellulase Compositions
04/08/2010US20100087335 siRNA targeting spleen tyrosine kinase
04/08/2010US20100087334 siRNA targeting superoxide dismutase 1 (SOD1)
04/08/2010US20100087005 Auxiliary reagent for gene transfer
04/08/2010US20100086995 Mhc class i peptide epitopes from the human 5t4 tumor-associated antigen
04/08/2010US20100086989 Mutant glucose dehydrogenase
04/08/2010US20100086986 Nitrilases and Methods for Making and Using Them
04/08/2010US20100086970 Thermus scotoductus nucleic acid polymerases
04/08/2010US20100086969 Antibodies That Bind to EphA2 and Methods of Use Thereof
04/08/2010US20100086942 Compounds
04/08/2010US20100086931 Method for assaying action of antitumor agent using decrease in gene expression level as index
04/08/2010US20100086922 Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment
04/08/2010US20100086918 Methods for High Sensitivity Detection of Genetic Polymorphisms
04/08/2010US20100086917 Isolated polynucleotides, nucleic acid constructs, methods and kits for localization of rna and/or polypeptides within living cells
04/08/2010US20100086916 Oligonucleotide probes and uses thereof
04/08/2010US20100086915 Detection of esr1 amplification in breast cancer
04/08/2010US20100086912 AZGP Gene Single Nucleotide Polymorphisms (SNPs)
04/08/2010US20100086911 Preventive/therapeutic agent for cancer
04/08/2010US20100086565 Vectors for expression of hml-2 polypeptides
04/08/2010US20100086564 West Nile Virus Vaccine
04/08/2010US20100086563 Compositions and Methods for Detection of Antibodies Specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl)
04/08/2010US20100086556 Use of hemagglutinin of the african swine fever virus as an adjuvant
04/08/2010US20100086555 Neutralizing anti-influenza a virus antibodies and uses thereof
04/08/2010US20100086543 Compositions and methods for treating conditions associated with ceramide biosynthesis
04/08/2010US20100086539 Method and preparations for the diagnosis and therapy of multiple sclerosis and immune demyelinating polyneuropathy
04/08/2010US20100086538 Antibody Molecules Which Bind to Human IL-17
04/08/2010US20100086533 Laglidadg homing endonuclease variants having novel substrate specificity and use thereof
04/08/2010US20100086532 Chimeric zinc finger recombinases optimized for catalysis by directed evolution
04/08/2010US20100086516 Cytokine receptor chain
04/08/2010US20100086487 Papio cynocephalus Toll-Like Receptor 3
04/08/2010DE202009017108U1 Monoklonaler Antikörper gegen Microcephalin (MCPH1) Monoclonal antibodies against Microcephalin (MCPH1)
04/08/2010DE102005031755B9 Salmonella spp. Salmonella spp. bindende Peptide, dafür kodierende Nukleinsäuren, deren Verwendungen und Verfahren und Kits zur Anreicherung, Immobilisierung und zum Nachweis von Salmonella spp. binding peptides, nucleic acids encoding, uses thereof and methods and kits for enrichment, immobilization and detection of Salmonella spp.
04/08/2010CA2736430A1 Improved antibody libraries
04/07/2010EP2170935A2 Hpiv-2 variants and medical applications thereof
04/07/2010EP2170929A2 Peptides facilitating retrograde transport and their uses
04/07/2010EP2170924A2 5-bromo-2'-deoxy-uridine labeled nucleotide triphosphates and nucleic acid probes and methods of making and using the same
04/07/2010EP2170922A1 Nucleic acid sample preparation by exclusion of dna
04/07/2010EP2170917A2 N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
04/07/2010EP2170776A2 Hybrid solid supports useful for oligonucleotide production
04/07/2010EP2170404A2 Compositions comprising human egfr-sirna and methods of use
04/07/2010EP1692182B1 Cd20 antibodies with increased fc receptor binding affinity and effector function
04/07/2010EP1412513B1 Phosphate limited inducible promoter and a bacillus expression system
04/07/2010CN1873010B Preparation method and application of using transgene carrier of peanut Ara h3 promoter
04/07/2010CN101692090A Use of biomarkers for detecting ovarian cancer
04/06/2010US7692064 Expression vector comprising nucleotide sequences coding ammonium transport protein for use in enhancement of nitrogen assimilation in plants
04/06/2010US7692061 Maize cellulose synthase encoding sequences and uses thereof
04/06/2010US7691999 RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)
04/06/2010US7691998 siRNA targeting nucleoporin 62kDa (Nup62)
04/06/2010US7691997 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing
04/06/2010US7691996 Nuclelotide sequences comprising one to three phosphorothioate 2'-modified ribonucleotides, a biotin group, and a P-alkyloxyphosphotriester nucleotide for use as targeting tools in gene expression inhibition
04/06/2010US7691995 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes
04/06/2010US7691994 Compositions and methods for the detection of human T cell receptor variable family gene expression
04/06/2010US7691993 Fusion proteins of Mycobacterium tuberculosis
04/06/2010US7691992 Nucleic acids encoding the human ALEX1 protein
04/06/2010US7691991 Sequence-determined DNA fragments encoding cytochrome P450 proteins
04/06/2010US7691990 Employs a procedure in which a DNA intercalator contained in liquid or gas is selectively adsorbed onto DNA by contacting the DNA with the DNA intercalator; capable of selectively adsorbing dioxin and dioxin-like substances with high efficiency and of easily enhancing throughput
04/06/2010US7691988 DNA in the presence of gellan
04/06/2010US7691987 Use of a novel eimeria gene and corresponding protein
04/06/2010US7691977 Anti-VEGF antibodies
04/06/2010US7691965 Helical synthetic peptides that stimulate cellular cholesterol efflux
04/06/2010US7691824 Double-stranded ribonucleic acid (dsRNA), and its use in mediating RNA interference to inhibit the expression of one of the genes of the JC virus and the use of the dsRNA to treat pathological processes mediated by JC virus infection, such as PML; sense, antisense
04/06/2010US7691821 Inhibition of SHIP to enhance stem cell harvest and transplantation
04/06/2010US7691815 Methods for blocking TNF-alpha activity in mammals with trimeric soluble TNF receptors
04/06/2010US7691787 Target molecule attachment to surfaces
04/06/2010US7691635 Such as heat resistant diazomethyl compounds; kits for solid phase nucleic acid synthesis
04/06/2010US7691632 Kit for detecting the level of cyclin-dependent kinase inhibitor P16 gene expression
04/06/2010US7691627 Nucleic acid sequences encoding D1 and D1/D2 domains of human coxsackievirus and adenovirus receptor (CAR)
04/06/2010US7691619 for production of a rare sugar using genetic engineering; catalyzes an isomerization reaction from L-rhamnose to L-rhamnulose and also an isomerization reaction from L-rhamnulose to L-rhamnose; production of D-allose
04/06/2010US7691617 Acid-stable alpha amylases having granular starch hydrolyzing activity and enzyme compositions
04/06/2010US7691616 Cytochrome P450 oxygenases
04/06/2010US7691614 Method of genome-wide nucleic acid fingerprinting of functional regions
04/06/2010US7691613 Glycosaminoglycan lyase IV and uses thereof
04/06/2010US7691612 Heparan sulfate glycosaminoglycan lyase and uses thereof
04/06/2010US7691610 Vectors and host cells for Zven biodrug production; agents that stimulate gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis
04/06/2010US7691608 Nucleic acids encoding recombinant protein A
04/06/2010US7691605 Selection of cells expressing heteromeric polypeptides
04/06/2010US7691575 identifying a composition that increase immune response; Asteraceae plant extract; identifying stable compositions for increasing endogenous cytokine levels
04/06/2010US7691574 Methods for monitoring multiple gene expression
04/06/2010US7691571 Detection of bordetella
04/06/2010US7691569 detecting the expression level of a nucleic acid depending upon the rate of hematopoiesis or the distribution of hematopoietic cells along their maturation pathway in patient
04/06/2010US7691405 Biodrug delivery; SiRNA, cationic lipid CLinDMA, Cholesterol, and a polvethyleneglycol-diacylglycamide (PEG-DAG)
04/06/2010US7691395 BASB119 polypeptide and polynucleotide from Moraxella catarrhalis
04/06/2010US7691385 Polypeptides encoded by polynucleotides that are useful for detecting resistance to streptogramin A or to streptogramin B and related compounds
04/06/2010US7691370 Selectivity replicating viral vector
04/06/2010US7691330 Substrate is contacted by a channel block having channels through which selected reagents are delivered; the substrate is rotated by a rotating stage and the process is repeated to form arrays of products on the substrate; may be combined with light-directed methodolgies
04/06/2010CA2378925C Matrix-targeted fusion polypeptides for tissue regeneration and wound healing
04/06/2010CA2321070C Method and apparatus for synthesis of arrays of dna probes
04/06/2010CA2219090C Universal targets for species identification
04/06/2010CA2193491C Replication-competent herpes simplex virus mediates destruction of neoplastic cells
04/06/2010CA2161867C Means for detecting familial colon cancer (fcc)
04/03/2010CA2640415A1 Methods for predicting and detecting intolerance to an hypolipidemic agent
04/01/2010WO2010036979A2 Novel vectors for production of interferon
04/01/2010WO2010036795A2 Screening methods for identifying specific staphylococcus aureus inhibitors